David Roman Analyst Performance

Analyst at The Goldman Sachs Group

David Roman is a stock analyst at The Goldman Sachs Group, covering 16 publicly traded companies across a range of sectors. Over the past year, David Roman has issued 12 stock ratings, including buy, hold, and sell recommendations. While full access to David Roman's proprietary MarketBeat Analyst Rating is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights David Roman's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rating: Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeat
Average Return: 00.00% 12-Month ROI
Success Rate: 00.00% Profitable Ratings
Total Ratings: 19 Last 10 Years
Buy Recommendations: 46.67% 7 Buy Ratings
Companies Covered: 16 Unique Companies

Ratings Distribution

Rating	Percentage	Count
Strong Buy	6.7%	1 ratings
Buy	40.0%	6 ratings
Hold	46.7%	7 ratings
Sell	6.7%	1 ratings

Out of 15 total stock ratings issued by David Roman at The Goldman Sachs Group, the majority (46.7%) have been Hold recommendations, followed by 40.0% Buy, 6.7% Strong Buy, and 6.7% Sell.

Best & Worst Calls

Best Call
000.0%
BAX
Jul 2016
Subscribe to MarketBeat All Access to get analyst recommendation ROI.
Worst Call
00.0%
ZLTQ
Oct 2015
Subscribe to MarketBeat All Access to get analyst recommendation ROI.

Exchange Coverage

Exchange	Percentage	Count
NASDAQ	56.3% of companies on NASDAQ	9 companies
NYSE	43.8% of companies on NYSE	7 companies

David Roman, an analyst at The Goldman Sachs Group, currently covers 16 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector Icon	Sector	Percentage
	Medical 13 companies	81.3%
	Miscellaneous 3 companies	18.8%

David Roman of The Goldman Sachs Group specializes in stock coverage within the Medical sector, with additional focus on companies.

Coverage Industries

Industry	Percentage
MED PRODUCTS 6 companies	37.5%
MEDICAL SERVICES 3 companies	18.8%
Miscellaneous 3 companies	18.8%
MED INSTRUMENTS 2 companies	12.5%
SURGICAL, MEDICAL, AND DENTAL INSTRUMENTS AND SUPPLIES 1 company	6.3%
PHARMACEUTICAL PREPARATIONS 1 company	6.3%

Time Frame

Start Date

End Date

Rating

12-Month ROIAll ROI

Export to Excel

Company	Report Date	Action	Report Date Price	12-Month Price Target	Rating
SI Shoulder Innovations	8/25/2025	Initiated Coverage	$12.63	$20.00	Buy
OMDA Omada Health	7/1/2025	Initiated Coverage	$18.30	$29.00	Buy
HQY HealthEquity	6/4/2025	Boost Price Target	$113.10	$104.00	Neutral
BBNX Beta Bionics	5/30/2025	Initiated Coverage	$15.36	$16.00	Neutral
ZBH Zimmer Biomet	5/6/2025	Lower Price Target	$90.83	$104.00	Neutral
KMTS Kestra Medical Technologies	3/31/2025	Initiated Coverage	$23.43	$24.00	Neutral
GEHC GE HealthCare Technologies	3/11/2025	Upgrade	$85.36	$100.00	Buy
ABT Abbott Laboratories	3/4/2025	Boost Price Target	$140.38	$154.00	Buy
SOLV Solventum	3/3/2025	Boost Price Target	$78.68	$71.00	Sell
BAX Baxter International	2/26/2025	Initiated Coverage	$36.00	$42.00	Buy
SYK Stryker	1/30/2025	Boost Price Target	$393.95	$427.00	Neutral
ISRG Intuitive Surgical	10/18/2024	Set Price Target	$521.89	$604.00

Stock Forecasts and Research Tools

Today's Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.